Many of the anticancer effects of PPARγ and PPARγ agonists are mediated indirectly from the actions of 15d-PGJ2, a biologically active cyclopentenone that induces cell cycle arrest and apoptosis in cancer cells [53]. The gene discussed is PPARG; the disease is cancer.